ADH4 and metabolic dysfunction-associated steatohepatitis: ADH4 has been suggested as a potential biomarker for NASH because of the alcohol produced by intestinal bacteria9, which metabolize a wide variety of substrates (e.g., ethanol) to produce ROS.